Andrei Kachmazov Larisa Bolotina Anna Kornietskaya Olesya Kuznetsova Maxim Ivanov Alexander Fedenko
10.3389/fonc.2022.953908
Front Oncol
2022 Sep 2;12:953908.
palb2 parp inhibitors parpi pdac molecular profiling pancreatic cancer precision oncology talazoparib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36119518/
Case Reports
PMC9478540
36119518
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
2022